Mark L. Fuerst

How do you prescribe triptans – generic meds, as monotherapy, via injection? Learn the best approach for your migraine patients.

Researchers investigate the 2-year and long-term results of resective surgery in children under 4 years old with epilepsy.

A Johns Hopkins team is designing the STIMband, a non-invasive brain-stimulating device that may provide at-home Parkinson treatment.

We present findings from 3 recent studies concerning multiple sclerosis research and treatment.

This study aims to identify demographic, medical, and psychosocial predictors of drug adherence in young children newly diagnosed with epilepsy.

About one-third of stroke patients have significant cognitive impairment within several months of the event, but what is their status in the long term?

Digital communities and online self-management tools have the potential to improve clinical outcomes among epilepsy patients.

Biomarkers in the blood may be an effective tool for diagnosis and personalized therapy. Learn more about this and two other studies regarding multiple sclerosis.

Learn about virtual reality systems and a functional therapy approach designed to promote quicker stroke recovery.

Drug therapy is the mainstay of seizure treatment. We present recent findings in anti-epileptic drug research.

Recent studies on MS are highlighted, including a possible new avenue for future therapies.

New, non-invasive methods can help detect which epilepsy patients may be having seizures and allow clinicians to respond rapidly or to better plan surgeries for patients who are refractory to medical therapy.

To stent or not to stent? We present 3 studies with opposing responses to this question.

Surgery may offer relief from debilitating migraines. View the results of 3 different procedures.

Several new studies feature developments in remyelination in MS. Oligodendrocyte precursor cells may be a promising target for MS treatments, and microRNA expression are perhaps an attractive MS biomarker.

Worse strokes are more likely to occur in patients who are resistant to aspirin. Better ways to identify those patients are needed.

This new guideline could change the approach many physicians take to treating a first seizure--and could improve patients’ lives.

A non-psychoactive component of the marijuana plant, cannabidiol in liquid form decreased seizures by an average of 50% across multiple types of severe epilepsy.

Highlights of recent findings about multiple sclerosis are summarized in this slide show.

Some patients who take aspirin have the potential for larger, more severe strokes. Highlights of the latest news about stroke are presented in this slide show.

Minimally invasive surgery to remove clots from the brain and other cutting-edge stroke news for neurologists highlighted the research and clinical program at the International Stroke Conference.

This treatment may be superior to current treatment for patients with severe multiple sclerosis that is not responding well to standard treatments.

Favorable long-term results for patients with hard-to-treat epilepsy who undergo brain surgery offer good information for decision-making and counseling.

Symptoms occur in nearly 1 in 5 adults who have epilepsy. Their presence may have severe implications for patients’ quality of life.

A new study indicates that infection with Helicobacter pylori might lower the risk of multiple sclerosis, at least in women. Pharmaceutical products could provide a novel means of treatment.

This report reflects the changing nature of guidelines toward evidence-based treatment rather than expert opinion. A companion piece will help translate evidence-based guidelines to clinical practice.

The largest study of its kind shows that 8 in 1000 people have epilepsy--a distinctly higher incidence than previously thought. Details and implications in this podcast.

This is a newly identified association between the conditions, and they may share a common underlying link.

By localizing the portion of the brain responsible for seizures and envisioning long-term outcomes, this imaging combination helps guide clinical decision making.